Targeted Services NovaBioAssays specializes in selective reaction monitoring and complex protein analysis including ADCs and glycoproteins, presenting a clear opportunity to upsell advanced MS capabilities to biopharma firms developing biologics and biosimilars.

Biologics Focus With expertise in antibody-drug conjugates and protein characterization, position NovaBioAssays as a partner for translational studies, biosimilar development, and quality control in biologics pipelines seeking precise quantitative and structural data.

Boston-area Advantage As a Greater Boston CRO, leverage proximity to leading biotech clusters for rapid project initiation, pilot studies, and long-term collaborations with local pharma, biotech startups, and academic collaborations seeking outsourced MS capabilities.

Scale and Flex Mid-market revenue range and specialized MS tech stack suggest opportunities for multi-project partnerships, method development, and assay validation services aimed at accelerating drug discovery timelines for mid-sized biotech companies.

Digital Footprint Current tech stack and website presence indicate readiness for digital outreach, client portals, and secure data exchange; coordinate targeted campaigns highlighting MS workflows, turnaround times, and regulatory-friendly reporting to convert inbound inquiries.